Clinical Trial Update: Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dabigatran etexilate with enoxaparin for prevention of venous thromboembolism after total hip arthroplasty; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2010-12-17